Bioproduction, purification, and application of polysialic acid
Polysialic acid (PSA) is a negatively charged linear homopolymer linked by N-acetylneuraminic acid and widely present in vertebrates and some pathogens. PSA, commonly found on cell surfaces as glycoproteins and glycolipids, plays important roles in intercellular adhesion, cell migration, and formation and remodeling of the neural system by regulating the adhesive property of nerve cell adhesion molecules. PSA with a molecular weight that can reach as high as 260 kDa also belongs to the group II capsule polysaccharide of neonatal meningitis-causing Escherichia coli K1. To date, much effort has been devoted to developing the biotechnological production of PSA. As a non-glycosaminoglycan, PSA is a non-immunogenic and biodegradable polysaccharide that can be used as a biomaterial in protein polysialylation, tissue engineering, and drug delivery. PSA can also combine with other macromolecules to form multifunctional composites. In this mini-review, the production, purification, and application of PSA are summarized to provide a basis for further PSA applications.
KeywordsPolysialic acid Non-immunogenicity Biomaterial Drug-controlled release Biological functions Biomaterial Fermentative production
This work is supported by the National Natural Science Foundation of China (No. 21778022), the Program of Introducing Talents of Discipline to Universities (111-2-06), the Fundamental Research Funds for the Central Universities (JUSRP51632A), and the National First-class Discipline Program of Light Industry Technology and Engineering (LITE2018-17).
Compliance with ethical standards
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflicts of interest
The authors declare that they have no conflict of interest.
- Berski S, van Bergeijk J, Schwarzer D, Stark Y, Kasper C, Scheper T, Grothe C, Gerardy-Schahn R, Kirschning A, Dräger G (2008) Synthesis and biological evaluation of a polysialic acid-based hydrogel as enzymatically degradable scaffold material for tissue engineering. Biomacromolecules 9:2353–2359CrossRefGoogle Scholar
- Kapre SV, Shaligram U (2012) Process for the preparation of highly pure polysialic acid of high molecular weights. WO Patent 0353732008Google Scholar
- Karlstetter M, Kopatz J, Aslanidis A, Shahraz A, Caramoy A, Linnartz-Gerlach B, Lin Y, Lückoff A, Fauser S, Düker K, Claude J, Wang Y, Ackermann J, Schmidt T, Hornung V, Skerka C, Langmann T, Neumann H (2016) Polysialic acid blocks mononuclear phagocyte reactivity, inhibits complement activation, and protects from vascular damage in the retina. EMBO Mol Med 9:154–166CrossRefGoogle Scholar
- Lin SL, Inoue Y, Inoue S (1999) Evaluation of high-performance anion-exchange chromatography with pulsed electrochemical and fluorometric detection for extensive application to the analysis of homologous series of oligo- and polysialic acids in bioactive molecules. Glycobiology 9:807–814CrossRefGoogle Scholar
- De Vries I, Schreiber S, Boßmann D, Hellmanna Z, Kopatzb J, Neumannb H, Beutel S (2018) Single-use membrane adsorbers for endotoxin removal and purification of endogenous polysialic acid from Escherichia coli K1. Biotechnol Rep, 2018, 17:110–116Google Scholar
- Williams S, Neumann A, Bremer I, Su Y, Dräger G, Kasper C, Behrens P (2015) Nanoporous silica nanoparticles as biomaterials: evaluation of different strategies for the functionalization with polysialic acid by step-by-step cytocompatibility testing. J Mater Sci-Mater M 26:125–141CrossRefGoogle Scholar
- Wu J-R, Zhan X-B, Lin Y (2008) Preparation and application of PEG-PSA block copolymer. CN Patent 201010111612.XGoogle Scholar